Vanda Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.80-$9.94 |
Market Cap | $426.7M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $216.1M |
Revenue Growth (YoY) | 7.6% |
Gross Profit (12 Mos) | $203M |
Diluted EPS | -$3.74 |
News
See moreYahoo Finance • 4 days ago
Sector Update: Health Care Stocks Mixed Late Afternoon
Yahoo Finance • 4 days ago
Sector Update: Health Care Stocks Advance in Afternoon Trading
Yahoo Finance • 2 months ago
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley
Yahoo Finance • 2 months ago
FDA Accepts Vanda's BLA For Imsidolimab In Generalized Pustular Psoriasis
About
CEO | Dr. Mihael H. Polymeropoulos M.D. |
CFO | Mr. Kevin Patrick Moran |
Address | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 533 |
